Striatal hypometabolism in premanifest and manifest Huntington's disease patients. 2016

Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
Nuclear Medicine Department, Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. dlopezmo@santpau.cat.

OBJECTIVE To assess metabolic changes in cerebral 18F-FDG PET/CT in premanifest and manifest Huntington's disease (HD) subjects compared to a control group and to correlate 18F-FDG uptake patterns with different disease stages. METHODS Thirty-three gene-expanded carriers (Eight males; mean age: 43 y/o; CAG > 39) were prospectively included. Based on the Unified Huntington's Disease Rating Scale Total Motor Score and the Total Functional Capacity, subjects were classified as premanifest (preHD = 15) and manifest (mHD = 18). Estimated time disease-onset was calculated using the Langbehn formula, which allowed classifying preHD as far-to (preHD-A) and close-to (PreHD-B) disease-onset. Eighteen properly matched participants were included as a control group (CG). All subjects underwent brain 18F-FDG PET/CT and MRI. 18F-FDG PET/CT were initially assessed by two nuclear medicine physicians identifying qualitative metabolic changes in the striatum. Quantitative analysis was performed using SPM8 with gray matter atrophy correction using the BPM toolbox. RESULTS Visual analysis showed a marked striatal hypometabolism in mHD. A normal striatal distribution of 18F-FDG uptake was observed for most of the preHD subjects. Quantitative analysis showed a significant striatal hypometabolism in mHD subjects compared to CG (p < 0.001 uncorrected, k = 50 voxels). In both preHD groups we observed a significant striatal hypometabolism with respect to CG (p < 0.001 uncorrected, k = 50 voxels). In mHD subjects we observed a significant striatal hypometabolism with respect to both preHD groups (p < 0.001 uncorrected, k = 50 voxels). CONCLUSIONS 18F-FDG PET/CT might be a helpful tool to identify patterns of glucose metabolism in the striatum across the stages of HD and might be relevant in assessing the clinical status of gene-expanded HD carriers due to the fact that dysfunctional glucose metabolism begins at early preHD stages of the disease. 18F-FDG PET/CT appears as a promising method to monitor the response to disease-modifying therapies even if applied in premanifest subjects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001928 Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function. Central Nervous System Metabolic Disorders,Encephalopathies, Metabolic,Metabolic Disorders, Brain,Acquired Metabolic Diseases, Brain,Acquired Metabolic Diseases, Nervous System,Acquired Metabolic Encephalopathies,Brain Diseases, Metabolic, Acquired,Brain Disorders, Metabolic,Brain Disorders, Metabolic, Acquired,Brain Syndrome, Metabolic,Brain Syndrome, Metabolic, Acquired,CNS Metabolic Disorders,CNS Metabolic Disorders, Acquired,Encephalopathy, Metabolic, Acquired,Metabolic Brain Diseases,Metabolic Brain Diseases, Acquired,Metabolic Brain Syndrome,Metabolic Brain Syndrome, Acquired,Metabolic Brain Syndromes,Metabolic Brain Syndromes, Acquired,Metabolic Diseases, Acquired, Nervous System,Metabolic Disorder, Central Nervous System, Acquired,Metabolic Disorders, CNS,Metabolic Disorders, CNS, Acquired,Metabolic Disorders, Central Nervous System,Metabolic Encephalopathies,Nervous System Acquired Metabolic Diseases,Acquired Metabolic Encephalopathy,Brain Disease, Metabolic,Brain Disorder, Metabolic,Brain Metabolic Disorder,Brain Metabolic Disorders,CNS Metabolic Disorder,Encephalopathies, Acquired Metabolic,Encephalopathy, Acquired Metabolic,Encephalopathy, Metabolic,Metabolic Brain Disease,Metabolic Brain Disorder,Metabolic Brain Disorders,Metabolic Disorder, Brain,Metabolic Disorder, CNS,Metabolic Encephalopathies, Acquired,Metabolic Encephalopathy,Metabolic Encephalopathy, Acquired
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006816 Huntington Disease A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4) Huntington Chorea,Juvenile Huntington Disease,Akinetic-Rigid Variant of Huntington Disease,Chorea, Chronic Progressive Hereditary (Huntington),Chronic Progressive Hereditary Chorea (Huntington),Huntington Chronic Progressive Hereditary Chorea,Huntington Disease, Akinetic-Rigid Variant,Huntington Disease, Juvenile,Huntington Disease, Juvenile-Onset,Huntington Disease, Late Onset,Huntington's Chorea,Huntington's Disease,Juvenile-Onset Huntington Disease,Late-Onset Huntington Disease,Progressive Chorea, Chronic Hereditary (Huntington),Progressive Chorea, Hereditary, Chronic (Huntington),Akinetic Rigid Variant of Huntington Disease,Chorea, Huntington,Chorea, Huntington's,Huntington Disease, Akinetic Rigid Variant,Huntington Disease, Juvenile Onset,Huntington Disease, Late-Onset,Juvenile Onset Huntington Disease,Late Onset Huntington Disease
D000072078 Positron Emission Tomography Computed Tomography An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session. CT PET,CT PET Scan,PET CT Scan,PET-CT,PET-CT Scan,Positron Emission Tomography-Computed Tomography,CT PET Scans,CT Scan, PET,CT Scans, PET,PET CT Scans,PET Scan, CT,PET Scans, CT,PET-CT Scans,Scan, CT PET,Scan, PET CT,Scan, PET-CT,Scans, CT PET,Scans, PET CT,Scans, PET-CT
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
March 2023, International journal of molecular sciences,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
November 2019, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
July 2017, Journal of neurology, neurosurgery, and psychiatry,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
January 2013, Journal of Huntington's disease,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
October 2018, Scientific reports,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
April 2008, Neuropsychologia,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
November 2020, Brain and behavior,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
March 2014, Movement disorders : official journal of the Movement Disorder Society,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
January 2011, Journal of motor behavior,
Diego Alfonso López-Mora, and Valle Camacho, and Jesús Pérez-Pérez, and Saül Martínez-Horta, and Alejandro Fernández, and Frederic Sampedro, and Alberto Montes, and Gloria Andrea Lozano-Martínez, and Beatriz Gómez-Anson, and Jaime Kulisevsky, and Ignasi Carrió
October 2014, Neuroscience,
Copied contents to your clipboard!